Harbin Pharmaceutical Group Co., Ltd.

XSSC:600664 Stock Report

Market Cap: CN¥9.3b

Harbin Pharmaceutical Group Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure2.1yrs
Board average tenure2.4yrs

Recent management updates

Recent updates

CEO

Harbin Pharmaceutical Group has no CEO, or we have no data on them.

Leadership Team

NamePositionTenureCompensationOwnership
Bo Jiang
CFO & VP3.8yrsCN¥1.31mno data
Xiaodong Meng
VP & Secretaryless than a yearCN¥1.31m0.013%
CN¥ 1.2m
Haitao Jiang
Vice President2.6yrsCN¥691.90k0.0019%
CN¥ 177.0k
Jicheng Xia
Vice President2.1yrsCN¥467.60k0.0032%
CN¥ 294.7k
Bangdong Li
Vice President2.1yrsCN¥578.60k0.0016%
CN¥ 147.4k

2.1yrs

Average Tenure

51yo

Average Age

Experienced Management: 600664's management team is considered experienced (2.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Aidong Lou
Independent Director3.8yrsCN¥150.00kno data
Weihong Lu
Independent Director3.8yrsCN¥150.00kno data
Zhaohua Li
Independent Director3.8yrsCN¥150.00kno data
Ying Lei
Independent Directorless than a yearno datano data
Xiaoping Hu
Chairman3.8yrsno datano data
Shiwei Yin
Director2.8yrsno datano data
Zhifeng Sun
Director2.4yrsno datano data
Fangju Qiu
Employee Supervisorless than a yearno data0.000080%
CN¥ 7.4k
Liu Mo
Directorless than a yearno datano data
Cheng Peng
Supervisorless than a yearno datano data
Wenguang Peng
Chairman of the Supervisory Boardless than a yearno datano data

2.4yrs

Average Tenure

49yo

Average Age

Experienced Board: 600664's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.